The global preventive healthcare technologies and services market size is expected to reach USD 432.4 billion by 2024, according to a new report by Grand View Research, Inc. Key factors driving the market expansion include the growing awareness about preventive measures, which enhance the quality of life, lifespan, and minimize the possible healthcare spending.
The growth of this market is attributed to the adoption of advanced technology and the development of preventive measures, including vaccines, screening & monitoring devices, and smart devices to reduce medical errors. Growth of the market is also fueled by factors such as reducing the birth rate that is resulting in an increase of the geriatric population, which is more prone to chronic diseases.
With the introduction of the Human Development Index (HDI) ratings since 2010, all countries are engaged in the overall development of their country and citizens. Life expectancy has a significant impact on HDI calculations. Governments of the countries have been focusing on improving life expectancy of the people by implementing various programs, including free or affordable vaccination, smoking cessation, and affordable insurance schemes. These programs cause a direct positive impact on preventable technologies and services space.
A large share of preventive healthcare includes early detection and screening technology. This segment pertains to personalized diagnostic techniques, which has captured the largest share owing to the accuracy and availability of the innovative techniques for diagnosis.
To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/preventive-healthcare-technologies-and-services-market
Further Key Findings From the Study Suggest:
According to data published by the WHO, the percentage of the total vaccinations in the U.S. has been growing. The vaccinations included those funded by the government as well as private purchases.
In 2015, the early detection and screening technologies’ segment captured the largest share. The advantages associated with personalized medicine technologies, such as high accuracy and detection of the possible disease or disorder at an early stage, are mainly attributed to the largest share of the segment.
With the introduction of advanced technology and the growing demand for accurate screening methods, the growth of early detection and screening is expected to be the fastest during the forecast period.
North American region dominated this space by capturing over 48.0% of the global market in 2015. This region is anticipated to dominate the preventive healthcare technologies and services market throughout the forecast period. Some of the factors having a significant impact on the regional market growth are government initiatives, high per capita income, and the presence of a large number of major players in the region.
Growing economies and government initiatives are expected to drive the growth of the Asia Pacific region. The segment is expected to witness a lucrative CAGR of over 15% during the forecast period.
Some major players in the consolidated market are McKesson Corporation; Scripto LLC; Omnicell, Inc.; Healthways, Inc.; Alere; Medtronic; GlaxoSmithKline plc; Pfizer, Inc.; and Merck & Co, Inc.
Grand View Research has segmented the global preventive healthcare technologies and services market by product and region:
Preventive Healthcare Technologies And Services (Type) Outlook (Market revenue in USD Million, 2014 - 2024)
Early detection and screening technologies
Automated screening
Personalized medicine
Other advanced screening technologies
Chronic disease management technologies
Blood pressure monitors
Asthma monitors
Cardiovascular monitors
Glucose monitors
Vaccines
Infectious Diseases Vaccine
Cancer Vaccine
Autism Vaccine
Allergy Vaccine
Other new vaccines
Advanced technologies to reduce errors
Electronic prescribing
Clinical decision supports system
Smart infusion pumps
Computerized provider order entry system
Smart packaging and automated prescription formulation and dispensing
Preventive Healthcare Technologies And Services regional outlook (Market Revenue in USD Million, 2014 - 2024)
North America
The U.S.
Canada
Europe
The U.K.
Germany
Asia Pacific
Japan
China
Latin America
Brazil
Mexico
The Middle East and Africa
South Africa
Saudi Arabia
This report has a service guarantee. We stand by our report quality.
Your transaction & personal information is safe and secure.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
Avail customized purchase options to meet your research needs:
"The quality of research they have done for us has been excellent..."